Drugs / serrapeptase
last change Sep 2025 re-read 2 minutes ago

serrapeptase

Protein / enzyme biologic

Developed for
pulpitis
Investigated by
Sharif Medical Research Center · University of Science and Technology, Yemen

Trials 2 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT07304882 Nov 2023 → Jan 2025 impacted teeth, multiple University of Science and Technology, Yemen Completed No outcome recorded
Phase not applicable1 trial
NCT07543146 Jun → Sep 2025 Sharif Medical Research Center Completed No outcome recorded
Also used as a comparator or background therapy in 2 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT07146997 Comparator Nov 2023 → Nov 2024 pulpitis Zahoor khan Completed No outcome recorded
Phase not applicable1 trial
NCT03177889 Background Dec 2021 → Aug 2023 bronchiectasis Guangzhou Institute of Respiratory Disease Unknown No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as serrapeptase “oral mucolytics [ambroxol 30mg tid, or N-acetylcysteine 0.2g tid, serrapeptase 10mg tid, or carbocisteine 500mg tid]” NCT03177889
Known as Aniflazym ChEMBL registry synonym — accepted as the source's own label CHEMBL2108880
Known as Irzaim ChEMBL registry synonym — accepted as the source's own label CHEMBL2108880
Known as Serralysin ChEMBL registry synonym — accepted as the source's own label CHEMBL2108880
Known as Serrapeptasa ChEMBL registry synonym — accepted as the source's own label CHEMBL2108880
Known as Serratiopeptidase ClinicalTrials.gov intervention name — accepted as the source's own label NCT07543146
2

NCT07304882

NCT07146997

Action Inhibit “possibly inhibiting prostaglandin production” NCT07146997
Modality Protein / enzyme biologic “Serratiopeptidase is a proteolytic enzyme” NCT07146997
Route Oral oral mucolytics” NCT03177889